Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

£0.5 Million DHT Boost for Humane Research

Published: Monday, October 29, 2012
Last Updated: Monday, October 29, 2012
Bookmark and Share
Call for applications for next wave of grant funding also announced.

The Dr Hadwen Trust (DHT) has announced grants totalling £577,687, funding innovative and humane research into Alzheimer’s disease, Parkinson’s disease, oesophageal cancer, brain tumours and toxicology.

The research projects will be undertaken at five universities in England and Scotland. Their collective aim is to further the understanding and treatment of life threatening diseases while simultaneously developing alternative methods to replace the use of animals in biomedical research.

The potential number of animals to be saved from invasive and painful procedures as a result of the success of these projects is immeasurable.

The new projects aim to:
• Improve understanding of the role of proteins in development and cell function that will lead to a better understanding and treatment of Alzheimer’s disease (Royal Holloway University)

• Develop the use of plant cells to emulate the development of Parkinson’s disease in human cells (Westminster University)

• Three dimensional cell model to allow the study of Barrett’s oesophagus and its progression to cancer (Dundee University)

• Generate human liver cells from pluripotent human stem cells to replace animals in toxicology (Edinburgh University)

• Utilize an effective 3D blood-brain barrier model to identify nanoparticle systems which may be effective drug carriers used to combat brain tumours and other neurological diseases (Portsmouth University)

Kailah Eglington, Chief Executive of the Dr Hadwen Trust, said: “We are delighted to announce funding for a further five ground-breaking, new research projects which promise to deliver benefits to both humans and animals. Each of these projects promises to significantly increase our understanding of devastating diseases whilst replacing animals used in scientific research.”

To find out more about the DHT research grants, please visit: www.drhadwentrust.org/research-and-funding/current-portfolio.

2012 Call for Grant Applications
The DHT is also making its annual call for applications for the next wave of grants: www.drhadwentrust.org/research-and-funding/research-funding-overview.

Awarded in summer 2013, the deadline for preliminary applications is 17th December 2012.

Kailah Eglington, continues: “In making research grants available annually, we are urging all scientists to think about how they can help shape a more effective and humane future for medical research by using non-animal methods in their work.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!